trustmebro.to/r/…
✓ checked
trust me, bro:
here is the receipt.
the claim

Probiotics exist that specifically target upper respiratory tract tissue

the verdict
SUPPORTED
the evidence backs this
Recorded sources
6 sources for · 0 against

Counts group repeated records of the same source within each side. They do not measure evidence strength or source independence.

Is it true that probiotics exist that specifically target upper respiratory tract tissue?

Yes. Clinical and review evidence demonstrates that specific probiotic strains, such as Streptococcus salivarius administered via nasal spray or lozenge, are designed and shown to target upper respiratory tract tissue to prevent and reduce infections.

Verdict: SUPPORTED · 6 sources for, 0 against · Last checked

The analysis

The retrieved papers consistently demonstrate that certain probiotic strains (e.g., Streptococcus salivarius 24SMB and K12) are specifically formulated and administered (such as via nasal sprays or oral targets) for the upper respiratory tract to prevent infections. There is robust evidence supporting this claim and no papers refuting the existence of such targeted probiotics.

Evidence for · 6
Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a nasal spray for treatment of upper respiratory tract infections in children: a pilot study on short-term efficacy
2020
Demonstrates the use of Streptococcus salivarius nasal sprays specifically to treat upper respiratory tract issues.
Get citation
Manti, S., Parisi, G., Papale, M., Licari, A., Salpietro, C., Giudice, M. M. d., Marseglia, G., & Leonardi, S. (2020). Bacteriotherapy with Streptococcus salivarius 24SMB and Streptococcus oralis 89a nasal spray for treatment of upper respiratory tract infections in children: a pilot study on short-term efficacy. doi.org. https://doi.org/10.1186/s13052-020-0798-4

See more details
More for · 5
Streptococcus salivarius Role as a Probiotic in Children’s Health and Disease Prophylaxis—A Systematic Review
2024
Reviews the prophylactic use of S. salivarius strains like 24SMB via intranasal administration to target respiratory disease.
Get citation
Al-Akel, F., Chiperi, L., Eszter, V. K., & Bacârea, A. (2024). Streptococcus salivarius Role as a Probiotic in Children’s Health and Disease Prophylaxis—A Systematic Review. doi.org. https://doi.org/10.3390/life14121613

Efficacy of Streptococcus salivarius Blis K12 in the Prevention of Upper Respiratory Tract Infections in Physically Active Individuals: A Randomized Controlled Trial
2024
Shows that Streptococcus salivarius K12 successfully prevents upper respiratory tract infections in clinical trials.
Get citation
Bertuccioli, A., Cardinali, M., Micucci, M., Rocchi, M., Palazzi, C. M., Zonzini, G., Annibalini, G., Belli, A., & Sisti, D. (2024). Efficacy of Streptococcus salivarius Blis K12 in the Prevention of Upper Respiratory Tract Infections in Physically Active Individuals: A Randomized Controlled Trial. doi.org. https://doi.org/10.3390/microorganisms12112164

Review of Streptococcus salivarius BLIS K12 in the Prevention and Modulation of Viral Infections
2025
Highlights how bacteriocin-producing probiotics specifically target infections within the upper respiratory tract.
Get citation
Tagg, J., Harold, L. K., & Hale, J. D. F. (2025). Review of Streptococcus salivarius BLIS K12 in the Prevention and Modulation of Viral Infections. doi.org. https://doi.org/10.3390/applmicrobiol5010007

The response of nasal epithelial cells exposed to novel Lactobacillus and alpha-haemolytic Streptococcus isolated from the upper respiratory tract of children.
2025
Examines the direct response of nasal epithelial cells to novel and commercial probiotic strains targeted for the respiratory tract.
Get citation
Yarlagadda, T., Carey, A., Bryan, E., Huygens, F., Yarlagadda, P. K. D. V., Maresco-Pennisi, D., Coleman, A., Cervin, A., & Spann, K. M. (2025). The response of nasal epithelial cells exposed to novel Lactobacillus and alpha-haemolytic Streptococcus isolated from the upper respiratory tract of children.. doi.org. https://doi.org/10.1093/jambio/lxaf071

Streptococcus salivarius K12: A comprehensive review on its role as a probiotic in pediatric and general health
2025
Discusses the role of S. salivarius K12 as a targeted probiotic for enhancing upper respiratory tract health.
Get citation
Iragamreddy, V. R. (2025). Streptococcus salivarius K12: A comprehensive review on its role as a probiotic in pediatric and general health. doi.org. https://doi.org/10.30574/wjbphs.2025.21.1.0022

What does the evidence say?

The retrieved papers consistently demonstrate that certain probiotic strains (e.g., Streptococcus salivarius 24SMB and K12) are specifically formulated and administered (such as via nasal sprays or oral targets) for the upper respiratory tract to prevent infections. There is robust evidence supporting this claim and no papers refuting the existence of such targeted probiotics.

Receipt History
first checked31 Jul 2026
judged → SUPPORTED · 8431 Jul 2026
Anyone with this link can read the claim and its public receipt, including any personal information in that text. Open permanent receipt.
Check your own claim
Challenge the receipt
Requests are recorded for review. This does not start an automatic check or guarantee a response time.

See the evidence timeline

Citation formatting by citeproc-js (Frank Bennett) and the Citation Style Language project. Source and licenses.

This receipt is an automated verdict against our published method · not an opinion about any author or publication.
Terms · Privacy · How verdicts work